Sign in

CIK 0001662774

  • Non-accelerated filer
  • Smaller reporting company

IRulya Therapeutics Inc.

Sign in to watch
Ticker
IRLA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
901024039
Phone
+1 203-208-8994
Business address
101 COLLEGE STREET, SUITE 210, NEW HAVEN, CT, 06510
Former names
Quince Therapeutics, Inc., Cortexyme, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2022-03-03 Detke Michael J. Chief Medical Officer Grant or award +140,000 140,000
2022-01-03 Detke Michael J. Chief Medical Officer Grant or award · Stock Option (right to buy) +125,000 125,000
2021-08-10 Detke Michael J. Chief Medical Officer Exercise or conversion +10,000 $2.23 $22K 10,000
2021-08-10 Detke Michael J. Chief Medical Officer Sale −10,000 $100.00 $1.0M 0
2021-08-10 Detke Michael J. Chief Medical Officer Exercise or conversion · Stock Option (right to buy) −10,000 92,352
2021-07-07 Detke Michael J. Chief Medical Officer Exercise or conversion +17,400 $2.23 $39K 17,400
2021-07-07 Detke Michael J. Chief Medical Officer Sale −3,934 $53.24 $209K 13,466
2021-07-07 Detke Michael J. Chief Medical Officer Sale −1,648 $54.37 $90K 11,818
2021-07-07 Detke Michael J. Chief Medical Officer Sale −4,353 $55.38 $241K 7,465
2021-07-07 Detke Michael J. Chief Medical Officer Sale −6,942 $56.27 $391K 523
2021-07-07 Detke Michael J. Chief Medical Officer Sale −523 $56.99 $30K 0
2021-07-07 Detke Michael J. Chief Medical Officer Exercise or conversion · Stock Option (right to buy) −17,400 102,352
2021-07-06 Detke Michael J. Chief Medical Officer Exercise or conversion +12,600 $2.23 $28K 40,861
2021-07-06 Detke Michael J. Chief Medical Officer Sale −32,313 $53.43 $1.7M 8,548
2021-07-06 Detke Michael J. Chief Medical Officer Sale −8,260 $53.91 $445K 288
2021-07-06 Detke Michael J. Chief Medical Officer Sale −288 $55.01 $16K 0
2021-07-06 Detke Michael J. Chief Medical Officer Exercise or conversion · Stock Option (right to buy) −12,600 119,752
2020-12-11 Detke Michael J. Chief Medical Officer Grant or award · Stock Option (Right to Buy) +100,000 100,000
2020-12-11 Detke Michael J. Chief Medical Officer Grant or award · Stock Option (Right to Buy) +100,000 100,000
2020-05-27 Detke Michael J. Chief Medical Officer Exercise or conversion +5,515 $6.91 $38K 28,261

Page 1 of 2 · 26 trades